Automated, cost-effective production of mRNA vaccines as well as cell and gene therapeutics

mRNA-based vaccines and gene/cell therapeutics open up new possibilities for medical practitioners in the fight against cancer and infectious or hereditary diseases. However, manufacturing these innovative pharmaceuticals is an expensive and time-consuming process. The Fraunhofer RNAuto lighthouse p…